fenofibrate
Selected indexed studies
- Fenofibrate treatment for severe hypertriglyceridemia in dogs. (Domest Anim Endocrinol, 2021) [PMID:33137654]
- Beyond lipids: fenofibrate in diabetic retinopathy and nephropathy. (Trends Pharmacol Sci, 2026) [PMID:40835560]
- Impact of fenofibrate on NAFLD/NASH: A genetic perspective. (Drug Discov Today, 2022) [PMID:35569762]
_Worker-drafted node — pending editorial review._
Connections
fenofibrate is a side effect of
Sources
- Fenofibrate treatment for severe hypertriglyceridemia in dogs. (2021) pubmed
- Beyond lipids: fenofibrate in diabetic retinopathy and nephropathy. (2026) pubmed
- Impact of fenofibrate on NAFLD/NASH: A genetic perspective. (2022) pubmed
- Fenofibrate Exerts Protective Effects in Diabetic Retinopathy. (2025) pubmed
- Fenofibrate and the kidney: an overview. (2013) pubmed
- Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression. (2024) pubmed
- Update on fenofibrate. (2002) pubmed
- Pharmacology of fenofibrate. (1987) pubmed
- Fenofibrate, homocysteine and renal function. (2010) pubmed
- Fenofibrate: a review of its use in dyslipidaemia. (2011) pubmed